Tanaka T, Kaijima M, Tanaka S, Kunimoto M, Yonemasu Y
Department of Neurosurgery, Asahikawa Medical College, Japan.
No To Shinkei. 1988 Oct;40(10):987-91.
Flunarizine (Flu), a difluoro derivative of cinnarizine, is well known as a calcium channel blocker. Recently, many authors have reported an antiepileptic effect of this drug in experimental models of epilepsy and in the clinical use. In the present study, acute effect of Flu was examined in the amygdaloid kindled cats, and add-on effects of Flu with valproic acid (VA) was also studied. Twenty three cats were used in this study. Amygdaloid kindling was established as previously reported. A strength of stimulations for kindling was at 300 microA. Same strength was used after completion of kindling. In this "high intensity" kindling, daily stimulation invariably induced initial amygdalo-hippocampal seizures followed by secondarily generalized seizures after completion of kindling. In addition, one amygdaloid stimulation was given daily for 5 days after completion of kindling in order to make it certain to induce secondarily generalized seizures. Drugs were injected on the 6th day intraperitoneally one or two hours before the stimulation daily given for 5 days after completion of kindling (GS 6) or after 4 days clearance period of previous administration of the drug. Pretreatment with Flu (high doses: 30 or 50 mg/kg, i.p.) abolished the secondary generalization after the GS 6. With this high doses of Flu animals died of side effect within 3 days after intraperitoneal administration. With lower doses of Flu less than 3 mg/kg, i.p. of Flu no side effect was encountered but antiepileptic effect was not obtained as well. Then add-on trials of Flu were performed with valproic acid (VA). The most effective combination was 100 mg/kg, i.p. of VA with 3 mg/kg, i.p. of Flu. With this combination, secondary generalization was suppressed at a ratio of 54.5% The results confirmed antiepileptic effect of Flu and add-on effect of Flu to VA.(ABSTRACT TRUNCATED AT 250 WORDS)
氟桂利嗪(Flu)是桂利嗪的二氟衍生物,作为一种钙通道阻滞剂而广为人知。最近,许多作者报道了该药在癫痫实验模型和临床应用中的抗癫痫作用。在本研究中,检测了氟桂利嗪对杏仁核点燃猫的急性作用,并研究了氟桂利嗪与丙戊酸(VA)的联合附加作用。本研究使用了23只猫。如先前报道建立杏仁核点燃模型。点燃刺激强度为300微安。点燃完成后使用相同强度刺激。在这种“高强度”点燃模型中,每日刺激总是先诱发杏仁核 - 海马癫痫发作,点燃完成后继而出现继发性全身性癫痫发作。此外,点燃完成后每日给予一次杏仁核刺激,持续5天,以确保诱发继发性全身性癫痫发作。在点燃完成后第6天(GS 6)或前次给药4天清除期后,每天在刺激前一或两小时腹腔注射药物,持续5天。氟桂利嗪预处理(高剂量:30或50毫克/千克,腹腔注射)可消除GS 6后的继发性全身性发作。使用这种高剂量氟桂利嗪,动物在腹腔注射后3天内死于副作用。使用低于3毫克/千克腹腔注射的低剂量氟桂利嗪未出现副作用,但也未获得抗癫痫效果。然后进行氟桂利嗪与丙戊酸(VA)的联合附加试验。最有效的组合是100毫克/千克腹腔注射的VA与3毫克/千克腹腔注射的氟桂利嗪。采用这种组合,继发性全身性发作的抑制率为54.5%。结果证实了氟桂利嗪的抗癫痫作用以及氟桂利嗪与VA的联合附加作用。(摘要截取自250字)